Emerald Health Pharmaceuticals Demonstrates Repair of Nerve Damage Related to Multiple Sclerosis: Preclinical data show remyelination with the clinical-stage drug product candidate, EHP-101 July 2, 2019https://www.globenewswire.com/news-release/2019/07/02/1877329/0/en/Emerald-Health-Pharmaceuticals-Demonstrates-Repair-of-Nerve-Damage-Related-to-Multiple-Sclerosis.html